Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
暂无分享,去创建一个
[1] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Jejunum and Ileum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 906 Cases Before Imatinib With Long-term Follow-up , 2006, The American journal of surgical pathology.
[2] L. Sobin,et al. Gastrointestinal Stromal Tumors in Patients With Neurofibromatosis 1: A Clinicopathologic and Molecular Genetic Study of 45 Cases , 2006, The American journal of surgical pathology.
[3] J. Stachura,et al. GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology , 2006, Laboratory Investigation.
[4] J. Jónasson,et al. Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification study , 2005, International journal of cancer.
[5] H. Schlitt,et al. Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era. , 2005, American journal of clinical pathology.
[6] S. Jang,et al. Multiple gastrointestinal stromal tumors with a germline c‐kit mutation , 2005, Pathology international.
[7] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Stomach in Children and Young Adults: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases With Long-Term Follow-Up and Review of the Literature , 2005, The American journal of surgical pathology.
[8] H. Joensuu,et al. NF1-Associated Gastrointestinal Stromal Tumors Have Unique Clinical, Phenotypic, and Genotypic Characteristics , 2005, The American journal of surgical pathology.
[9] A. Llombart‐Bosch,et al. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Markku Miettinen,et al. KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic Correlation , 2005, Applied immunohistochemistry & molecular morphology : AIMM.
[11] M. Heinrich,et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] C. Antonescu,et al. A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E. , 2005, Cancer research.
[13] P. Pauwels,et al. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall , 2005, Histopathology.
[14] M. Fukayama,et al. Gastrointestinal Stromal Tumors of Neurofibromatosis Type I (von Recklinghausen's Disease) , 2005, The American journal of surgical pathology.
[15] C. Antonescu,et al. Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation , 2005, Clinical Cancer Research.
[16] Adrian A Canutescu,et al. Analysis of KIT Mutations in Sporadic and Familial Gastrointestinal Stromal Tumors: Therapeutic Implications through Protein Modeling , 2005, Clinical Cancer Research.
[17] M. van de Rijn,et al. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] N. Socci,et al. Gastrointestinal Stromal Tumors in Children and Young Adults: A Clinicopathologic, Molecular, and Genomic Study of 15 Cases and Review of the Literature , 2005, Journal of pediatric hematology/oncology.
[19] R. Yantiss,et al. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study , 2005, Modern Pathology.
[20] B. Nilsson,et al. Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era , 2005, Cancer.
[21] E. Wardelmann,et al. PDGFRα‐ and c‐kit‐mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features , 2005 .
[22] P. Marynen,et al. Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. , 2005, Gastroenterology.
[23] I. Hernán,et al. Novel c‐KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation , 2005, American journal of medical genetics. Part A.
[24] J. Lee,et al. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases , 2005, Laboratory Investigation.
[25] A. Hartmann,et al. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] C. Corless,et al. State-of-the Art Therapy for Gastrointestinal Stromal Tumors , 2005, Cancer investigation.
[27] L. Sobin,et al. Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up , 2005, The American journal of surgical pathology.
[28] M. Sabripour,et al. Imatinib resistance in gastrointestinal stromal tumors , 2005, Current oncology reports.
[29] Y. Kitamura,et al. Kit as a human oncogenic tyrosine kinase. , 2004, Cellular and molecular life sciences : CMLS.
[30] Y. Kitamura,et al. Oncogenic protein tyrosine kinases , 2004, Cellular and Molecular Life Sciences CMLS.
[31] J. Fletcher,et al. Biology of gastrointestinal stromal tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] E. Wardelmann,et al. Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. , 2004, The Journal of molecular diagnostics : JMD.
[33] A. Hagemeijer,et al. Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site , 2004, Modern Pathology.
[34] J. Fletcher,et al. Protein Kinase C θ (PKCθ) Expression and Constitutive Activation in Gastrointestinal Stromal Tumors (GISTs) , 2004, Cancer Research.
[35] J. Fletcher,et al. KIT-Negative Gastrointestinal Stromal Tumors: Proof of Concept and Therapeutic Implications , 2004, The American journal of surgical pathology.
[36] Angela Greco,et al. A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. , 2004, Gastroenterology.
[37] L. Sobin,et al. A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential , 2004, Laboratory Investigation.
[38] C. Ball,et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. , 2004, The American journal of pathology.
[39] E. Campo,et al. Protein Kinase C θ Is Highly Expressed in Gastrointestinal Stromal Tumors But Not in Other Mesenchymal Neoplasias , 2004, Clinical Cancer Research.
[40] Tsuyoshi Saito,et al. c-kit and PDGFRA Mutations in Extragastrointestinal Stromal Tumor (Gastrointestinal Stromal Tumor of the Soft Tissue) , 2004, The American journal of surgical pathology.
[41] C. Antonescu,et al. Pleomorphic Characteristics of a Germ-Line KIT Mutation in a Large Kindred with Gastrointestinal Stromal Tumors, Hyperpigmentation, and Dysphagia , 2004, Clinical Cancer Research.
[42] S. Hirota,et al. Absence of c‐kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients , 2004, The Journal of pathology.
[43] P. Terrier,et al. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. , 2004, Gastroenterology.
[44] A. D. Van den Abbeele,et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] R. Schneider-Stock,et al. KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin. , 2003, Human pathology.
[46] S. Steigen,et al. Gastrointestinal Stromal Tumors with Internal Tandem Duplications in 3′ End of KIT Juxtamembrane Domain Occur Predominantly in Stomach and Generally Seem to Have a Favorable Course , 2003, Modern Pathology.
[47] E. Wardelmann,et al. Deletion of Trp‐557 and Lys‐558 in the juxtamembrane domain of the c‐kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors , 2003, International journal of cancer.
[48] L. Pylkkänen,et al. Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors. , 2003, Human pathology.
[49] M. Ladanyi,et al. Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] C. Antonescu,et al. Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[51] A. Franchi,et al. An Osteoclast-Rich Tumor of the Gastrointestinal Tract with Features Resembling Clear Cell Sarcoma of Soft Parts: Reports of 6 Casesof aGIST Simulator , 2003, International Journal of Surgical Pathology.
[52] D. Weaver,et al. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. , 2003, American journal of clinical pathology.
[53] Samuel Singer,et al. PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.
[54] L. Sobin,et al. Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Duodenum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 167 Cases , 2001, The American journal of surgical pathology.
[55] J. Lasota,et al. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. , 2003, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[56] Y. Matsuzawa,et al. Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours , 2002, Gut.
[57] E. Montgomery,et al. &bgr;-Catenin Immunohistochemistry Separates Mesenteric Fibromatosis From Gastrointestinal Stromal Tumor and Sclerosing Mesenteritis , 2002, The American journal of surgical pathology.
[58] Tony Pawson,et al. Regulation and targets of receptor tyrosine kinases. , 2002, European journal of cancer.
[59] A. D. Van den Abbeele,et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.
[60] U. Lendahl,et al. Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas * , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[61] L. Sobin,et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.
[62] R. Yantiss,et al. Gastrointestinal Stromal Tumors: An Ultrastructural Study , 2002, International journal of surgical pathology.
[63] C. Stratakis,et al. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. , 2002, American journal of medical genetics.
[64] L. Sobin,et al. Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps? , 2002, Human pathology.
[65] C. J. Chen,et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. , 2001, Cancer research.
[66] L. Sobin,et al. Mesenchymal Tumors of Muscularis Mucosae of Colon and Rectum are Benign Leiomyomas that Should be Separated from Gastrointestinal Stromal Tumors—A Clinicopathologic and Immunohistochemical Study of Eighty-Eight Cases , 2001, Modern Pathology.
[67] T. Jacks,et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications , 2001, Oncogene.
[68] J. W. Griffin,et al. Gastrointestinal Autonomic Nerve Tumor: Immunohistochemical and Molecular Identity With Gastrointestinal Stromal Tumor , 2001, The American journal of surgical pathology.
[69] C. Capella,et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa , 2001, Cancer.
[70] L. Sobin,et al. Schwannomas in the Colon and Rectum: A Clinicopathologic and Immunohistochemical Study of 20 Cases , 2001, The American journal of surgical pathology.
[71] Y. Ma,et al. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. , 2001, Leukemia research.
[72] U. Lendahl,et al. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. , 2001, The American journal of pathology.
[73] A. Kuraishi,et al. Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene. , 2001, Gastroenterology.
[74] S. Hirota,et al. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. , 2000, The American journal of pathology.
[75] L. Sobin,et al. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. , 2000, The American journal of pathology.
[76] P. D. Dal Cin,et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.
[77] S. Knuutila,et al. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. , 2000, Cancer research.
[78] C. Compton,et al. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. , 2000, The American journal of surgical pathology.
[79] Robert H Lyles,et al. Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of Outcome , 2000, Modern Pathology.
[80] J. Fletcher,et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. , 2000, The American journal of pathology.
[81] S. Hirota,et al. Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene. , 2000, The American journal of surgical pathology.
[82] L. Sobin,et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. , 1999, The American journal of surgical pathology.
[83] S. Hirota,et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. , 1999, Cancer research.
[84] A. Kovatich,et al. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[85] S Torihashi,et al. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype. , 1999, Gastroenterology.
[86] J. Carney,et al. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. , 1999, Mayo Clinic proceedings.
[87] J. Lasota,et al. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. , 1999, The American journal of pathology.
[88] M. Fukayama,et al. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. , 1999, The American journal of pathology.
[89] R. Parwaresch,et al. Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. , 1998, Human pathology.
[90] S. Hirota,et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene , 1998, Nature Genetics.
[91] Coffin Cm,et al. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. , 1998, Seminars in diagnostic pathology.
[92] L. Kindblom,et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. , 1998, The American journal of pathology.
[93] S. Hirota,et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.
[94] J. Goldblum,et al. Stromal tumors of the jejunum and ileum: a clinicopathologic study of 39 cases. , 1997, The American journal of surgical pathology.
[95] S. Knuutila,et al. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. , 1996, Cancer research.
[96] S. Hirota,et al. Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats. , 1995, Gastroenterology.
[97] John Malysz,et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity , 1995, Nature.
[98] S. Nishikawa,et al. Requirement of c-kit for development of intestinal pacemaker system. , 1992, Development.
[99] K. Min,et al. Small Intestinal Stromal Tumors With Skeinoid Fibers: Clinicopathological, Immunohistochemical, and Ultrastructural Investigations , 1992, The American journal of surgical pathology.
[100] G. Stenman,et al. Human PDGFA receptor gene maps to the same region on chromosome 4 as the KIT oncogene , 1989, Genes, chromosomes & cancer.
[101] M. Enjoji,et al. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. , 1988, Human pathology.
[102] J. Coindre,et al. Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system , 1984, International journal of cancer.